AI assistant
Sending…
Lexaria Bioscience Corp. — Director's Dealing 2019
Aug 16, 2019
34983_dirs_2019-08-16_8efc5455-7110-471e-920f-6589d3e31ed3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Lexaria Bioscience Corp. (LXRP)
CIK: 0001348362
Period of Report: 2019-08-15
Reporting Person: Quigley Brian W. (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-08-15 | Stock Options | $0.81 | A | 100000 | Acquired | 2024-08-15 | Common Shares (100000) | Direct |
More from Lexaria Bioscience Corp.
Interim / Quarterly Report
2026
Apr 13
Director's Dealing
2026
Mar 18
Delisting Announcement
2026
Feb 6
Regulatory Filings
2026
Jan 28
Declaration of Voting Results & Voting Rights Announcements
2026
Jan 28
Capital/Financing Update
2026
Jan 14
Delisting Announcement
2026
Jan 14
Interim / Quarterly Report
2026
Jan 13
Capital/Financing Update
2025
Dec 29
Regulatory Filings
2025
Dec 19